Page last updated: 2024-11-03

proadifen and Breast Cancer

proadifen has been researched along with Breast Cancer in 2 studies

Proadifen: An inhibitor of drug metabolism and CYTOCHROME P-450 ENZYME SYSTEM activity.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kretschy, N1
Teichmann, M1
Kopf, S1
Atanasov, AG1
Saiko, P1
Vonach, C1
Viola, K1
Giessrigl, B1
Huttary, N1
Raab, I1
Krieger, S1
Jäger, W1
Szekeres, T1
Nijman, SM1
Mikulits, W1
Dirsch, VM1
Dolznig, H1
Grusch, M1
Krupitza, G1
Watts, CK1
Sutherland, RL1

Other Studies

2 other studies available for proadifen and Breast Cancer

ArticleYear
In vitro inhibition of breast cancer spheroid-induced lymphendothelial defects resembling intravasation into the lymphatic vasculature by acetohexamide, isoxsuprine, nifedipin and proadifen.
    British journal of cancer, 2013, Feb-19, Volume: 108, Issue:3

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Acetohexamide; Antineoplastic Combined Chemotherapy Prot

2013
Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Molecular pharmacology, 1987, Volume: 31, Issue:5

    Topics: Animals; Breast Neoplasms; Cell Line; Cyclofenil; Estrogen Antagonists; Humans; Microsomes; Nitromif

1987